search
Back to results

Effect of Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults (ScenoProt) (ScenoProt)

Primary Purpose

Colorectal Cancer, Type2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
70% animal, 30% plant proteins in diet
50% animal, 50% plant proteins in diet
30% animal, 70% plant proteins in diet
Sponsored by
University of Helsinki
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer focused on measuring colorectal cancer, type 2 diabetes, diet, plant protein, animal protein

Eligibility Criteria

20 Years - 69 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Healthy, no exclusion criteria listed below.

Exclusion Criteria:

Strict vegan, food allergies, oral medication for any allergies, regular use of food supplements, extreme sports, inflammatory bowel disease, colon irritable, caeliac disease, any kind of cancer within 5 years, continuous antibiotics or less than three months of the latest antibiotics use, type 1 or 2 diabetes, hormonal, liver or kidney disease, pregnancy, lactation.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Active Comparator

    Experimental

    Experimental

    Arm Label

    70% animal, 30% plant proteins in diet

    50% animal, 50% plant proteins in diet

    30% animal, 70% plant proteins in diet

    Arm Description

    Dietary proteins from animal sources 70% and from plant sources 30%, representing an average Finnish diet consumed at the moment.

    Dietary proteins from animal sources 50% and from plant sources 50%, containing at most 500 g red meat/week (according to the current Finnish Nutrition Recommendations).

    Dietary proteins from animal sources 30% and from plant sources 70%.

    Outcomes

    Primary Outcome Measures

    Changes in the composition of gut microbiota and glucose metabolism as measures of modification of dietary protein composition
    The composition of gut microbiota is measured using HITChip phylogenetic microarray. Glucose tolerance test is carried out to analyze glucose metabolism in the beginning and in the end of the intervention.
    Changes in the intake of nutrients and nutritional status of participants as a measure of diet modification
    The changes in the markers for nutritional status in the blood: vit. D25-OH, carotenoids, vitamin C and B12, ferritin, alkyl resorcinols. The intake of nutrients is calculated from 4-day food diaries.

    Secondary Outcome Measures

    Changes in the concentrations of metabolites derived from plant and animal-based foods in fecal water and urine
    Concentrations of metabolites derived from plant-based foods in fecal water are measured using UPLC (ultra performance liquid chromatography). Concentrations of fecal nitroso compounds as a measure of red meat consumption is measured as apparent total nitroso compounds.
    Genotoxicity testing of human fecal water in 2D and 3D cell cultures
    Fecal water is isolated from fecal samples collected in the beginning and in the end of intervention period. The samples are tested for markers of genotoxicity in 2D and 3D cell cultures.

    Full Information

    First Posted
    June 30, 2017
    Last Updated
    September 24, 2021
    Sponsor
    University of Helsinki
    Collaborators
    Natural Resources Institute Finland, Makery Ltd, Finland
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03206827
    Brief Title
    Effect of Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults (ScenoProt)
    Acronym
    ScenoProt
    Official Title
    Effects of Dietary Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2021
    Overall Recruitment Status
    Completed
    Study Start Date
    November 29, 2016 (Actual)
    Primary Completion Date
    June 30, 2017 (Actual)
    Study Completion Date
    September 24, 2021 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Helsinki
    Collaborators
    Natural Resources Institute Finland, Makery Ltd, Finland

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The aim of this study is to investigate the effects of dietary plant and animal proteins on gut metabolism and markers for colorectal cancer as well as blood protein metabolites and markers for type 2 diabetes in healthy adults. The study participants will be stratified into three groups with different protein composition in diets: 1) animal 70%/plant 30%; 2) animal 50%/plant 50% and 3) animal 30%/plant 70%. The participants will get part of their diet as ready foods or raw material to promote their compliance. The participants will also get personal advice for their diets. Blood, stool and urine samples will be collected in the beginning and in the end of the 12 week intervention, as well as phenotype measures like BMI, blood pressure and body composition. The participants will also fill food diary before and in the end of the intervention.
    Detailed Description
    A human intervention study with healthy volunteers will be carried out to compare the effects of animal and plant-based protein sources on gut metabolism and markers for colorectal cancer as well as blood protein metabolites and markers for type 2 diabetes. The study will be done in parallel-design, randomized fashion, with healthy human volunteers aged 20 - 69 years. Exclusion criteria will be as follows: strict vegan, regular user of fish oil or other food supplements, extreme sports, inflammatory bowel disease, colon irritable, celiac disease, continuous antibiotics or less than three months of the latest antibiotics use, type 2 diabetes and hormonal, liver or kidney disease. Duration of the intervention will be 12 weeks. Intervention groups will be as follows (n=50/group): Group 1: Dietary proteins from animal sources 70% and from plant sources 30%, representing an average Finnish diet consumed at the moment. Group 2: Dietary proteins from animal sources 50% and from plant sources 50%, containing at most 500 g red meat/week (according to the current Finnish Nutrition Recommendations). Group 3: Dietary proteins from animal sources 30% and from plant sources 70%. The intake of total protein will be kept at similar level compared to habitual, but intakes of fat and carbohydrates may vary as composing a diet with plant-based protein sources inevitably causes changes for example in dietary fibre intake. We will aim at controlling other potential dietary confounders to the extent that is possible in a whole-diet approach. This will ensure the feasibility of the diets and facilitate future applications in dietary practices at the population level. Before starting the intervention, the persons will get dietary advice how to fulfill their diets. They will get part of foods free to help to implement the diets and to enhance compliance. Blood, urine and fecal samples will be collected at the baseline (at the beginning of the intervention) and at the end of the intervention. Dietary intake and food consumption during the intervention will be followed by 3-day food records in the beginning and at the end of the intervention period. Nutrient intakes will be calculated using AIVO program. The following data collection and analyses will be carried out at the beginning and at the end of intervention: height, weight, waist circumference body composition by bioelectrical impedance analysis resting blood pressure, hemoglobin fasting lipid profile in the blood (total cholesterol, LDL and HDL, triglycerides) fasting glucose and insulin, HbA1c in the blood markers for low-grade inflammation in the blood: hs-CRP, cytokines such as IL-1beta, IL-6, IL-10 protein metabolomics in the blood markers of nutritional status in the bood: vit. D25-OH, carotenoids, vitamin C and B12, alkyl resorcinols urea/nitrogen in the urine measures of gut metabolism and risk markers for colorectal cancer: total N-nitroso compounds in the feces, plant-derived polyphenol metabolites in the feces, concentration of bile acids, cytotoxicity and genotoxicity assays of fecal water samples in 2D and 3D colon cancer cell cultures and gut microbiota analyses.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colorectal Cancer, Type2 Diabetes
    Keywords
    colorectal cancer, type 2 diabetes, diet, plant protein, animal protein

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    147 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    70% animal, 30% plant proteins in diet
    Arm Type
    Active Comparator
    Arm Description
    Dietary proteins from animal sources 70% and from plant sources 30%, representing an average Finnish diet consumed at the moment.
    Arm Title
    50% animal, 50% plant proteins in diet
    Arm Type
    Experimental
    Arm Description
    Dietary proteins from animal sources 50% and from plant sources 50%, containing at most 500 g red meat/week (according to the current Finnish Nutrition Recommendations).
    Arm Title
    30% animal, 70% plant proteins in diet
    Arm Type
    Experimental
    Arm Description
    Dietary proteins from animal sources 30% and from plant sources 70%.
    Intervention Type
    Other
    Intervention Name(s)
    70% animal, 30% plant proteins in diet
    Intervention Description
    Diet contains 70% of proteins from animal sources (beef, pork, chicken, dairy products, fish) and 30% from plant sources (bread and cereals).
    Intervention Type
    Other
    Intervention Name(s)
    50% animal, 50% plant proteins in diet
    Intervention Description
    Diet contains 50% of proteins from animal sources (beef, pork, chicken, dairy products, fish) and 50% from plant sources (bread and cereals, legumes, nuts, seeds, soy products).
    Intervention Type
    Other
    Intervention Name(s)
    30% animal, 70% plant proteins in diet
    Intervention Description
    Diet contains 30% of proteins from animal sources (beef, pork, chicken, dairy products, fish) and 70% from plant sources (bread and cereals, legumes, nuts, seeds, soy products).
    Primary Outcome Measure Information:
    Title
    Changes in the composition of gut microbiota and glucose metabolism as measures of modification of dietary protein composition
    Description
    The composition of gut microbiota is measured using HITChip phylogenetic microarray. Glucose tolerance test is carried out to analyze glucose metabolism in the beginning and in the end of the intervention.
    Time Frame
    12 weeks
    Title
    Changes in the intake of nutrients and nutritional status of participants as a measure of diet modification
    Description
    The changes in the markers for nutritional status in the blood: vit. D25-OH, carotenoids, vitamin C and B12, ferritin, alkyl resorcinols. The intake of nutrients is calculated from 4-day food diaries.
    Time Frame
    12 weeks
    Secondary Outcome Measure Information:
    Title
    Changes in the concentrations of metabolites derived from plant and animal-based foods in fecal water and urine
    Description
    Concentrations of metabolites derived from plant-based foods in fecal water are measured using UPLC (ultra performance liquid chromatography). Concentrations of fecal nitroso compounds as a measure of red meat consumption is measured as apparent total nitroso compounds.
    Time Frame
    12 weeks
    Title
    Genotoxicity testing of human fecal water in 2D and 3D cell cultures
    Description
    Fecal water is isolated from fecal samples collected in the beginning and in the end of intervention period. The samples are tested for markers of genotoxicity in 2D and 3D cell cultures.
    Time Frame
    12 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    69 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Healthy, no exclusion criteria listed below. Exclusion Criteria: Strict vegan, food allergies, oral medication for any allergies, regular use of food supplements, extreme sports, inflammatory bowel disease, colon irritable, caeliac disease, any kind of cancer within 5 years, continuous antibiotics or less than three months of the latest antibiotics use, type 1 or 2 diabetes, hormonal, liver or kidney disease, pregnancy, lactation.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Anne-Maria Pajari, PhD
    Organizational Affiliation
    University of Helsinki
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    34837522
    Citation
    Pellinen T, Paivarinta E, Isotalo J, Lehtovirta M, Itkonen ST, Korkalo L, Erkkola M, Pajari AM. Replacing dietary animal-source proteins with plant-source proteins changes dietary intake and status of vitamins and minerals in healthy adults: a 12-week randomized controlled trial. Eur J Nutr. 2022 Apr;61(3):1391-1404. doi: 10.1007/s00394-021-02729-3. Epub 2021 Nov 27.
    Results Reference
    derived
    PubMed Identifier
    32939557
    Citation
    Itkonen ST, Paivarinta E, Pellinen T, Viitakangas H, Risteli J, Erkkola M, Lamberg-Allardt C, Pajari AM. Partial Replacement of Animal Proteins with Plant Proteins for 12 Weeks Accelerates Bone Turnover Among Healthy Adults: A Randomized Clinical Trial. J Nutr. 2021 Jan 4;151(1):11-19. doi: 10.1093/jn/nxaa264.
    Results Reference
    derived

    Learn more about this trial

    Effect of Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults (ScenoProt)

    We'll reach out to this number within 24 hrs